Paroxetine is a novel nitric oxide synthase inhibitor

Psychopharmacology Bulletin

Volumn 32, Issue 4, 1996, Pages 653-658

  Finkel, Mitchell S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

antidepressants; nitric oxide; nortriptyline; paroxetine

Indexed keywords

ARGININE; CITRULLINE; CYTOCHROME P450; NITRATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NORTRIPTYLINE; PAROXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL ISOLATION; CONFERENCE PAPER; DEPRESSION; ENZYME ACTIVITY; ENZYME INHIBITION; HAMSTER; ISCHEMIC HEART DISEASE; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RATING SCALE; STATISTICAL ANALYSIS;

ANIMALS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; NITRIC OXIDE SYNTHASE; PAPILLARY MUSCLES; PAROXETINE; SEROTONIN;

EID: 0030481783     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (1)

1. Arora, RC, and Meltzer, HY. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am. J. Psychiatry 146:730-736, 1989.